Global Immunofluorescence Assay Market Report and Forecast 2024-2032

Global Immunofluorescence Assay Market Outlook

The global immunofluorescence assay market attained a value of about USD 3.00 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 5.40% to reach nearly USD 4.81 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Accounts for a Significant Share of the Market for Immunofluorescence Assay

North America accounts for a significant share of the the immunofluorescence assays industry owing to the increasing incidences of chronic and infectious diseases. The increasing spending on research and development (R&D), the introduction of various favourable government initiatives, and the surging presence of major key players in the region are augmenting the market growth. The increasing automation of laboratories, the improving technology, and favourable reimbursement scenarios are increasing the demand for immunofluorescence assays, which is providing impetus to the growth of the market. With the growing deployment of immunofluorescence assays in the detection of viral antigens, in the wake of the COVID-19 pandemic, the market is witnessing robust growth.

Immunofluorescence Assay: Market Segmentation

Immunofluorescence assay is a staining or visualisation technique that is used to identify the existence of antibodies by their specific ability to react with viral antigens expressed in infected cells. In the technique, bound antibodies are visualised by incubation with fluorescently labelled anti-human antibodies and only specific cells are stained. Immunofluorescence assay can be used to analyse the distribution of proteins, glycans, and small biological and non-biological molecules. It is widely used in biological research and medical research.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major products of immunofluorescence assay are:

• Reagents and Kits
• Instruments
• Consumables and Accessories

On the basis of types, the market can be classified into:

• Indirect Immunofluorescence
• Direct Immunofluorescence

The market can be broadly categorised on the basis of applications into:

• Cancer
• Infectious Diseases
• Autoimmune Diseases
• Others

The EMR report looks into the regional markets of immunofluorescence assay like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Incidences of Chronic Diseases to Drive the Market Growth of Immunofluorescence Assay

The increasing incidences of chronic diseases like intestinal cancer, HIV AIDS, Alzheimer’s, diverticulitis, Crohn’s Disease, ulcerative colitis, and inflammatory bowel disease, among others, is driving the market growth of immunofluorescence assay. The rising availability of advanced kits and reagents and the increasing application of immunofluorescence assays in diagnostic and research studies are also accelerating market growth.

The surging research and development (R&D) activities for technological advancements and the increasing investments by governments in healthcare are expected to bolster the demand for immunofluorescence assays, which is estimated to propel the market growth. The increasing demand for robust healthcare facilities, the rising focus on antibody waste, therapeutics and several preclinical and clinical studies are predicted to fuel the market growth in the forecast period.

Key Industry Players in the Global Immunofluorescence Assay Market

The report presents a detailed analysis of the following key players in the global immunofluorescence assay market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Thermo Fisher Scientific Inc.
• Cell Signaling Technology, Inc.
• Bio-Rad Laboratories, Inc.
• Sino Biological Inc.
• PerkinElmer Inc.
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report